Andrew L’Huillier
Company: Merck
Job title: Director - Diagnostics & Regulatory Affairs Liaison
Seminars:
AI/ML Is Taking Over the World. Is it Taking Over CDx too? 11:30 am
Use cases for AI/ML in and alongside CDx Regulatory and practical challenges for AI/ML in CDx trials Where are we now and where are we going? Policy shifts for CDx and AI/ML and what it means for future developmentRead more
day: day 2
Chairs Closing Remarks 3:15 pm
day: day 2
Panel Discussion: Strategically Planning CDx Partnerships to Ensure Effective Relationships to Expedite Regulatory Approvals 12:00 pm
Early regulatory involvement in CDx partnerships Setting out clear expectations and requirements to establish effective relationships for quick development and regulatory approval of CDx Strategies to ensure seamless communication and collaboration between pharma, diagnostic developers and regulatory authoritiesRead more
day: day 2
Chair’s Opening Remarks 8:50 am
day: day 2
Chair’s Opening Remarks 8:50 am
day: day 1